electroCore, Inc. (ECOR)
NASDAQ: ECOR · Real-Time Price · USD
17.67
-1.32 (-6.95%)
At close: Feb 21, 2025, 4:00 PM
18.29
+0.62 (3.51%)
After-hours: Feb 21, 2025, 6:51 PM EST
electroCore Revenue
electroCore had revenue of $6.55M in the quarter ending September 30, 2024, with 45.39% growth. This brings the company's revenue in the last twelve months to $23.33M, up 74.10% year-over-year. In the year 2023, electroCore had annual revenue of $16.03M with 86.57% growth.
Revenue (ttm)
$23.33M
Revenue Growth
+74.10%
P/S Ratio
5.37
Revenue / Employee
$343,044
Employees
68
Market Cap
115.82M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 16.03M | 7.44M | 86.57% |
Dec 31, 2022 | 8.59M | 3.14M | 57.62% |
Dec 31, 2021 | 5.45M | 1.96M | 55.93% |
Dec 31, 2020 | 3.50M | 1.11M | 46.25% |
Dec 31, 2019 | 2.39M | 1.40M | 140.72% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ECOR News
- 18 days ago - electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - GlobeNewsWire
- 5 weeks ago - electroCore: An Opportunity In Medical And Wellness Device Innovation - Seeking Alpha
- 7 weeks ago - electroCore Has Only Just Begun To Scratch The Surface Of Its Huge TAM - Seeking Alpha
- 2 months ago - electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness - GlobeNewsWire
- 3 months ago - electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21 - GlobeNewsWire
- 3 months ago - electroCore, Inc. (ECOR) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - electroCore Announces Third Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - ElectroCore's Truvaga™ Plus Wins Men's Health Magazine Tech Award - GlobeNewsWire